The Biologic Era in COPD: What Mepolizumab Approval Means for Exacerbation Control

Published Date: 28 Aug 2025

In this video, the first in a 6-part series, panelists discuss the impact of monoclonal antibodies for COPD management.

Read Full News

Latest News

Air Trapping Predicts Pneumothorax After BLVR

Noninvasive analysis can help patients avoid in-hospital post-procedure monitoring.

Sanofi Says Rare Lung Disease Drug Outperforms Standard Care in Trial

(Corrects executive's name from Alaa Ahmed to Alaa Hamed in paragraphs 7 and 8)

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

Noninvasive analysis can help patients avoid in-hospital post-procedure monitoring.

(Corrects executive's name from Alaa Ahmed to Alaa Hamed in paragraphs 7 and 8)

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

News All Time

Doc Gave Patients Recalled CPAPs 'Fixed' by His Own Children

Sleep medicine specialist was sentenced to a year in prison and will pay $350K in restitution

Cooking and Dementia Risk; High-Dose vs Standard-Dose Flu Shot

Also in TTHealthWatch: replacing the aortic valve in asymptomatic people

Alzheimer's Risk May Be Influenced by Flu Shots

High-dose vaccine tied to roughly 20% lower risk of Alzheimer's dementia

Here's How Many Doctors and Nurses Are Getting Flu or COVID Shots

Nurses in particular do not seem to be fans of the COVID-19 vaccine

Trump: 'It Was Me as a Doctor'; Lululemon PFAS Probe; Dick Vitale's Fifth Cancer Dx

Health news and commentary gathered by MedPage Today staff

Quiz Time: How Are Flu Shots and Alzheimer's Linked?

You passed medical training, now see if you can pass our weekly quiz

Doc Detained by Border Patrol; Lady Gaga Sick, Cancels Show; Sexy Chocolate Recall

Health news and commentary gathered by MedPage Today staff

Amoxicillin Alone Holds Up for Acute Sinusitis

Observational study supports efficacy, safety compared with amoxicillin-clavulanate

Novel KRAS Drug Shows 'Excellent' Efficacy in Tough-to-Treat Lung Cancer

Zoldonrasib ideal for further evaluation in KRAS G12D-mutant disease, expert says

Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line

Zongertinib in phase I trial showed sustained efficacy in aggressive disease

Undetected TB May Be Lurking in U.S. Hospitals, Ultrasensitive Assay Suggests

Findings of TB DNA will require larger studies to confirm clinical relevance, says researcher

Congresswoman Tied to COVID Fraud Resigns; DOD Ends Flu Vax Mandate; USPSTF Overhaul

Health news and commentary gathered by MedPage Today staff

If It's COVID, Paxlovid? Studies Suggest a Rethink These Days

In a post-pandemic landscape, the drug didn't top usual care at stopping hospitalization, death

Bronchial Casts: An Unusual Complication of Wildfire Smoke Inhalation

Case is a "graphic demonstration" of emergent, severe impacts of forest fires for everyday people

Portable Tuberculosis Diagnostic Tool Matched Traditional Tests' Results

The MiniDock MTB could expand access to molecular testing in peripheral health centers

Why Is a Healthy 22-Year-Old Male Suddenly Fainting and Short of Breath?

Careful questioning about patient's recent behaviors gave vital clue

Recommended News For You

Safe and acceptable telehealth suicide prevention program.

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

Housing aid linked to lower medical financial hardship among US renters with cancer

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

According to research, the mineralization of the bone matrix controls the growth of tumor cells.

Herpes virus-based vaccine shows promise in targeting tumors without side effects

Recommended Articles For You

Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer 

Navigating the Complexity of Peritoneal Carcinomatosis: A Guide for Patients and Caregivers 

Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing 

Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

2.

Study identifies new approach to protect the brain during radiation therapy

3.

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

4.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

5.

Radiation therapy for patients with breast cancer

1.

Radiation in Oncology: Advances, Applications, and Accessibility

2.

The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review

3.

Cracking Oncology Drug Resistance: New Strategies to Overcome Challenges in Modern Cancer Therapy

4.

Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense

5.

Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

2.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

3.

Navigating the Complexities of Ph Negative ALL - Part XIII

4.

Navigating the Complexities of Ph Negative ALL - Part IV

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot